SCHEMBL3428811

SCHEMBL3428811

CC(=O)N1CCN(C(=O)c2ccc(NC(=O)C3(NC(=O)c4ccc(Cl)s4)CC4CCC3O4)cc2Cl)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.41
ALDH1A1 P00352 4/20 0.37
MAPT P10636 3/20 0.37
POLB P06746 2/20 0.37
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 4/20 0.36
MAPK1 P28482 2/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
NPC1 O15118 2/20 0.34
NFKB1 P19838 1/20 0.34
RAB9A P51151 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
EPHX2 P34913 3/20 0.34
PAX8 Q06710 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3426030 0.81 F10 (0.45) F10KDM4ENPSR1RXFP1
SCHEMBL3426176 0.80 CA12 (0.36) F10ALDH1A1MAPTLMNAHPGD
SCHEMBL6454562 0.76 F10 (0.40) F10ALDH1A1LMNAHPGDMAPK1
SCHEMBL4465179 0.73 F10 (0.41) F10ALDH1A1MAPTLMNAHPGD
SCHEMBL3421824 0.71 F10 (0.53) F10ALDH1A1MAPTHPGDMEN1
SCHEMBL4465122 0.71 F10 (0.47) F10
SCHEMBL4564715 0.71 F10 (0.44) F10ALDH1A1MAPTMEN1KMT2A
SCHEMBL4456137 0.71 F10 (0.44) F10ALDH1A1MAPTMEN1KMT2A
SCHEMBL5569097 0.70 MAPK14 (0.39) F10
SCHEMBL3427698 0.68 F10 (0.56) F10ALDH1A1POLBHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732466-B2 Substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-06-08 US disclosed
US-20060293300-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293300-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments OTC, TPMT, ABCG2 F10 1901/4885ALDH1A1 1734/4885MAPT 1066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.